Yahoo Finance17d
Renowned Investigators Awarded $8 Million NIH Grant to Study Lucid Diagnostics' EsoGuard® in At-Risk Patients without Symptomatic GERD
(PRNewsfoto/Lucid Diagnostics) "Patients without GERD symptoms account for nearly half of prevalent esophageal cancer cases," said Amitabh Chak, M.D., Professor of Medicine and Oncology at CWRU ...
Morningstar17d
Renowned Investigators Awarded $8 Million NIH Grant to Study Lucid Diagnostics' EsoGuard® in At-Risk Patients without Symptomatic GERD
To accomplish this aim, 800 patients without GERD symptoms who meet the American Gastroenterological Association's (AGA) risk criteria for screening will be recruited across five participating ...